So Entresto is ready to be rolled out in the US with a price tag of around $4,500 a year. Novartis has hinted at an outcomes-based pricing plan but there are no details of any scheme or how it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback